TABLE 1.
I: Evidence of widespread alveolar injury: |
---|
a. Multilobar infiltrates on routine chest radiographs or computed tomography |
b. Symptoms and signs of pneumonia (cough, dyspnea, tachypnea, rales) |
c. Evidence of abnormal pulmonary physiology |
1. Increased alveolar to arterial oxygen difference |
2. New or increased restrictive pulmonary function test abnormality |
II: Absence of active lower respiratory tract infection based upon: |
a. Bronchoalveolar lavage negative for significant bacterial pathogens including acid-fast bacilli, Nocardia, and Legionella species |
b. Bronchoalveolar lavage negative for pathogenic nonbacterial microorganisms: |
1. Routine culture for viruses and fungi |
2. Shell vial culture for CMV and respiratory RSV |
3. Cytology for CMV inclusions, fungi, and Pneumocystis jirovecii (carinii) |
4. Direct fluorescence staining with antibodies against CMV, RSV, HSV, VZV, influenza virus, parainfluenza virus, adenovirus, and other organisms |
c. Other organisms/tests to also consider: |
1. Polymerase chain reaction for human metapneumovirus, rhinovirus, coronavirus, and HHV6 |
2. Polymerase chain reaction for Chlamydia, Mycoplasma, and Aspergillus species |
3. Serum galactomannan ELISA for Aspergillus species |
d. Transbronchial biopsy if condition of the patient permits |
III: Absence of cardiac dysfunction, acute renal failure, or iatrogenic fluid overload as etiology for pulmonary dysfunction |
Definition of abbreviations: CMV = cytomegalovirus; HSV = herpes simplex virus; RSV = respiratory syncytial virus; VZV = varicella zoster virus.
Table updated from Reference 1.